A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment

PURPOSE: The aim of this audit was to assess the overall experience and patient convenience of vaginal progesterone tablets (Lutigest(®), marketed as Endometrin(®) in the USA) used for luteal phase support (LPS) during in vitro fertilization (IVF) treatment. PATIENTS AND METHODS: This questionnaire-...

Descripción completa

Detalles Bibliográficos
Autores principales: Heine, Polly, Sellar, Laura, Whitten, Sue, Bajaj, Priti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726362/
https://www.ncbi.nlm.nih.gov/pubmed/29263708
http://dx.doi.org/10.2147/PROM.S140678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726362/
https://www.ncbi.nlm.nih.gov/pubmed/29263708
http://dx.doi.org/10.2147/PROM.S140678

Ejemplares similares